ARTICLE | Financial News
Aeglea prices $12.3M follow-on
June 16, 2017 5:08 AM UTC
On June 6, enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) raised $12.3 million through the sale of 3 million shares at $4.10 in a follow-on underwritten by JonesTrading Institutiona...
BCIQ Company Profiles